P2.04-003 Phase II Trial of X-396 (Ensartinib) for Chinese Patients with ALK (+) Non–Small-Cell Lung Cancer Who Progressed on Crizotinib
JOURNAL OF THORACIC ONCOLOGY（2017）
关键词
crizotinib,X-396 (ensartinib),ALK-rearranged non-small-cell lung cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要